JasonRobertStubbsMD
Nephrology • Kansas City, KSAssociate Professor, Internal Medicine, University Kansas School of Medicine
Dr. Stubbs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3901 Rainbow Blvd
# MS3002
Kansas City, KS 66160Phone+1 913-588-6074Fax+1 913-588-3867
Education & Training
University of Kansas School of MedicineFellowship, Nephrology, 2005 - 2007- University of Kansas School of MedicineResidency, Internal Medicine, 2002 - 2005
- University of Kansas School of MedicineClass of 2002
Certifications & Licensure
KS State Medical License 2005 - 2025
MO State Medical License 2021 - 2025
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease Start of enrollment: 2008 May 01
- Impact of Vitamin D Therapies on Chronic Kidney Disease Start of enrollment: 2010 Oct 01
- Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- 39 citationsMicrobiome and Cardiovascular Disease in CKD.Anna Jovanovich, Tamara Isakova, Jason R. Stubbs
Clinical Journal of the American Society of Nephrology. 2018-10-08 - 146 citationsFGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophyChad D. Touchberry, Troy M. Green, Vladimir Tchikrizov, Jaimee E. Mannix, Tiffany F. Mao
American Journal of Physiology. Endocrinology and Metabolism. 2013-04-15 - 17 citationsTrimethylamine-N-oxide acutely increases cardiac muscle contractilityCarlee I. Oakley, Julian Vallejo, Derek Wang, Mark A. Gray, LeAnn M. Tiede-Lewis
American Journal of Physiology. Heart and Circulatory Physiology. 2020-04-03
Lectures
- Kidney, Bone, and Vasculature: Is the Gut a New Piece of the Puzzle?American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019
Other
- Overview of the causes and treatment of hyperphosphatemiaStubbs JR, Yu AS
http://www.uptodate.com/contents/overview-of-the-causes-and-treatment-of-hyperphosphatemia
UpToDate, Wolters Kluwer Health - 2013-03-04
Press Mentions
TMAO Implicated as a Cardiovascular Risk Factor in CKDAugust 5th, 2015
Grant Support
- Exploring The Interrelationships Of Mineral Metabolism Pathways In Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Clinical Trial: Extrarenal 1-Alpha-Hydroxylase In End-Stage Renal DiseaseNational Center For Research Resources2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
